☰ 🔍
🖊️Ask a Question
Electrical Engineering

Choose the correct statement about nateglinide: A. It is a long acting oral hypoglycaemic drug B. Taken just before a meal, it limits postprandial hyperglycaemia in type 2 diabetes mellitus C. It lowers blood glucose in both type 1 and type 2 diabetes mellitus D. It acts by opening K+ channels in myocytes and adipocytes

by 0 views
Choose the correct statement about nateglinide:
A. It is a long acting oral hypoglycaemic drug
B. Taken just before a meal, it limits postprandial hyperglycaemia in type 2 diabetes
mellitus
C. It lowers blood glucose in both type 1 and
type 2 diabetes mellitus
D. It acts by opening K+ channels in myocytes
and adipocytes
0 like 0 dislike

1 Answer

by
B. Taken just before a meal, it limits postprandial hyperglycaemia in type 2 diabetes
mellitus
0 like 0 dislike

Related questions

by trupti chikram asked Jul 22, 2021 0 views
Choose the correct statement(s) about pioglitazone: A. It acts as an agonist on nuclear paroxisome proliferator receptor γ B. It enhances transcription of insulin responsive genes C. It lowers blood sugar in type 2 diabetes mellitus without causing hyperinsulinemia D. All of the above

Choose the correct statement(s) about pioglitazone: A. It acts as an agonist on nuclear paroxisome proliferator receptor γ B. It enhances transcription of insulin responsive genes C. It lowers blood sugar in type 2 diabetes mellitus without causing hyperinsulinemia D. All of the above
Answer : D. All of the above...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 22, 2021 0 views
Which of the following is not a sulfonylurea but acts by analogous mechanism to bring about quick and brief insulin release that is useful for normalizing meal time glycaemic excursions in type 2 diabetes mellitus: A. Glimepiride B. Miglitol C. Repaglinide D. Rosiglitazone

Which of the following is not a sulfonylurea but acts by analogous mechanism to bring about quick and brief insulin release that is useful for normalizing meal time glycaemic excursions in type 2 diabetes mellitus: A. Glimepiride B. Miglitol C. Repaglinide D. Rosiglitazone
Answer : C. Repaglinide...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 24, 2021 0 views
Choose the correct statement about lovastatin: A. It markedly lowers plasma triglyceride with little effect on cholesterol level B. It is used as an adjuvant to gemfibrozil for type III hyperlipoproteinemia C. It is not effective in diabetes associated hypercholesterolemia D. It is a competitive inhibitor of the rate limiting step in cholesterol synthesis

Choose the correct statement about lovastatin: A. It markedly lowers plasma triglyceride with little effect on cholesterol level B. It is used as an adjuvant to gemfibrozil for type III ... hypercholesterolemia D. It is a competitive inhibitor of the rate limiting step in cholesterol synthesis
Answer : D. It is a competitive inhibitor of the rate limiting step in cholesterol synthesis...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 24, 2021 0 views
Choose the correct statement about trimetazidine: A. It is a novel calcium channel blocker B. It improves tissue perfusion by modifying rheological property of blood C. It is an antianginal drug which acts by nonhaemodynamic mechanisms D. Both 'A' and 'B' are correct

Choose the correct statement about trimetazidine: A. It is a novel calcium channel blocker B. It improves tissue perfusion by modifying rheological property of blood C. It is an antianginal drug which acts by nonhaemodynamic mechanisms D. Both 'A' and 'B' are correct
Answer : C. It is an antianginal drug which acts by nonhaemodynamic mechanisms...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 23, 2021 0 views
Choose the correct statement about lamotrigine: A. It is a dopaminergic agonist used in parkinsonism B. It acts by blocking NMDA-type of glutamate receptors C. It is a broad spectrum antiepileptic drug D. It suppresses tonic-clonic seizures, but worsens absence seizures

Choose the correct statement about lamotrigine: A. It is a dopaminergic agonist used in parkinsonism B. It acts by blocking NMDA-type of glutamate receptors C. It is a broad spectrum antiepileptic drug D. It suppresses tonic-clonic seizures, but worsens absence seizures
Answer : C. It is a broad spectrum antiepileptic drug...

View solution
0 like 0 dislike
1 answer

50.5k questions

47.1k answers

240 comments

7.0k users

© 2025 Question Answer